« Previous
Next »
European Journal of Internal Medicine
Volume 21, Issue 2
, Pages 114-117
, April 2010
Low prevalence of anti-RNA polymerase III antibodies in a French scleroderma population: Anti-RNA polymerase III scleroderma
References
- Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum. 2003;48:2246–2255
- . Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome. Arthritis Rheum. 1980;23:617–625
- . Evidence-based guidelines for the use of immunologic tests: anticentromere, Scl-70, and nucleolar antibodies. Arthritis Rheum. 2003;49:399–412
- . Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis. Br J Rheumatol. 1998;37:15–20
- . Autoantibodies to RNA polymerases recognize multiple subunits and demonstrate cross-reactivity with RNA polymerase complexes. Arthritis Rheum. 1999;42:275–284
- . Autoantibody reactive with three classes of RNA polymerases in sera from patients with systemic sclerosis. J Clin Invest. 1993;91:1399–1404
- . Identification of an immunodominant epitope on RNA polymerase III recognized by systemic sclerosis sera: application to enzyme-linked immunosorbent assay. Arthritis Rheum. 2002;46:2742–2747
- . Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies. Arthritis Rheum. 1994;37:902–906
- . Enzyme-linked immunosorbent assay for detection of anti-RNA polymerase III antibody: analytical accuracy and clinical associations in systemic sclerosis. Arthritis Rheum. 2005;52:2425–2432
- . Autoantibody reactive with RNA polymerase III in systemic sclerosis. Ann Intern Med. 1993;119:1005–1013
- . Antibodies to RNA polymerase III in systemic sclerosis detected by ELISA. J Rheumatol. 2007;34:1528–1534
- . Anti-RNA polymerase III antibodies in patients with systemic sclerosis detected by indirect immunofluorescence and ELISA. Rheumatology (Oxford). 2008;47:976–979
- Analysis of autoantibodies against RNA polymerases using immunoaffinity-purified RNA polymerase I, II, and III antigen in an enzyme-linked immunosorbent assay. Clin Immunol Immunopathol. 1998;89:71–78
- . Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis. J Rheumatol. 2007;34:104–109
- Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 1980;23:581–590
- Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15:202–205
- . Revised criteria for the classification of rheumatoid arthritis. Bull Rheum Dis. 1989;38:1–6
- Validation of a new immunoenzymatic method to detect antibodies to RNA polymerase III in systemic sclerosis. Clin Exp Rheumatol. 2007;25:373–377
- . Autoantibodies to RNA-polymerases in Italian patients with systemic sclerosis. Clin Exp Rheumatol. 2003;21:301–306
- . HLA class II alleles in systemic sclerosis patients with anti-RNA polymerase I/III antibody: associations with subunit reactivities. J Rheumatol. 2003;30:2392–2397
- Coexistence of antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis. Ann Rheum Dis. 2002;61:121–127
PII: S0953-6205(10)00007-5
doi: 10.1016/j.ejim.2010.01.004
© 2010 Elsevier B.V. All rights reserved.
« Previous
Next »
European Journal of Internal Medicine
Volume 21, Issue 2
, Pages 114-117
, April 2010
